XML 136 R28.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |  |
Schedule of Stock-based Compensation Expense | The Company recorded stock-based compensation expense in the following categories on the accompanying condensed consolidated statements of operations for the periods presented (in thousands): Schedule of Stock-based Compensation Expense
|  | 2024 |  |  | 2023 |
|  | Three Months Ended September 30, |
|  | 2024 |  |  | 2023 |
Cost of revenue |  | $ | 5 |  |  | $ | - |
General and administrative |  |  | 195 |  |  |  | 782 |
Sales and marketing |  |  | 2 |  |  |  | - |
Research and development |  |  | 5 |  |  |  | 16 |
Total stock-based compensation expense |  | $ | 207 |  |  | $ | 798 |
|  | 2024 |  |  | 2023 |
|  | Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |
Cost of revenue |  | $ | 13 |  |  | $ | - |
General and administrative |  |  | 416 |  |  |  | 1,014 |
Sales and marketing |  |  | 4 |  |  |  | - |
Research and development |  |  | 14 |  |  |  | 432 |
Total stock-based compensation expense |  | $ | 447 |  |  | $ | 1,446 |
| The Company recorded stock-based compensation expense in the following categories on the accompanying consolidated statements of operations for the periods presented (in thousands): Schedule of Stock-based Compensation Expense
|  | 2023 |  |  | 2022 |
|  | For the year ended December 31, |
|  | 2023 |  |  | 2022 |
Research and development |  | $ | 434 |  |  | $ | 638 |
General and administrative |  |  | 1,041 |  |  |  | 1,227 |
Total stock-based compensation expense |  | $ | 1,475 |  |  | $ | 1,865 |
Schedule of Options Outstanding |  | Information with respect to options outstanding is summarized as follows: Schedule of Options Outstanding
|  |  |  |  | Weighted |  |  | Aggregate |
|  | Number of |  |  | Average |  |  | Intrinsic |
|  | Options |  |  | Exercise Price |  |  | Value |
Outstanding as of December 31, 2021 |  |  | 728,603 |  |  | $ | 1.00 |  |  | $ | - |
Granted |  |  | 511,440 |  |  |  | 1.00 |  |  |  |  |
Exercised |  |  | (6,648 | ) |  |  | 1.00 |  |  |  |  |
Cancelled |  |  | (319,539 | ) |  |  | 1.00 |  |  |  |  |
Outstanding as of December 31, 2022 |  |  | 913,856 |  |  | $ | 1.00 |  |  | $ | 3,199 |
Exercised |  |  | (613,510 | ) |  |  | 1.00 |  |  |  |  |
Cancelled |  |  | (300,346 | ) |  |  | 1.00 |  |  |  |  |
Outstanding as of December 31, 2023 |  |  | - |  |  | $ | - |  |  | $ | - |
Vested and exercisable as of December 31, 2023 |  |  | - |  |  |  | - |  |  | $ | - |
Schedule of Fair Value of Stock Options | Schedule of Fair Value Assumptions and Valuation
|  | As of September 30, 2024 |
|  | PIPE |  |  | Business Combination |
|  | Warrants |  |  | Warrants |
Stock price |  | $ | 0.61 |  |  | $ | 0.61 |
Exercise price |  | $ | 10.00 |  |  | $ | 11.50 |
Expected volatility |  |  | 72.1 | % |  |  | 72.1 | %
Weighted average risk-free rate |  |  | 3.6 | % |  |  | 3.6 | %
Expected dividend yield |  |  | - |  |  |  | - |
Warrants measurement input |  |  | - |  |  |  | - |
Expected term (in years) |  |  | 4.1 |  |  |  | 4.2 |
| Schedule of Fair Value of Stock Options
|  | For the year ended December 31, |
|  | 2023 |  |  | 2022 |
Risk-free interest rate |  |  | - |  |  |  | 0.73% - 2.96 | %
Expected dividend yield |  |  | - |  |  |  | - |
Expected term in years |  |  | - |  |  |  | 1.36 - 1.85 |
Expected volatility |  |  | - |  |  |  | 50.0% - 86.3 | %
Schedule of Restricted Stock Award Activity |  | Schedule of Restricted Stock Award Activity
|  |  |  |  | Weighted |
|  | Number of |  |  | Average Grant |
|  | Awards |  |  | Date Fair Value |
Nonvested as of December 31, 2021 |  |  | - |  |  | $ | - |
Granted |  |  | 354,551 |  |  |  | 4.80 |
Vested |  |  | (177,276 | ) |  |  | 4.80 |
Nonvested as of December 31, 2022 |  |  | 177,275 |  |  | $ | 1.48 |
Granted |  |  | 88,639 |  |  |  | 7.21 |
Vested |  |  | (265,914 | ) |  |  | 5.60 |
Nonvested as of December 31, 2023 |  |  | - |  |  | $ | - |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an equity-based arrangement (such as stock or unit options and stock or unit awards) with an individual employee, which is generally an employment contract between the entity and a selected officer or key employee containing a promise by the employer to pay certain equity-based awards at future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period, the number of shares or units issued during the period under such arrangements, and the carrying amount as of the balance sheet date of the related liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 710 -SubTopic 10 -Name Accounting Standards Codification -Section 30 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483043/710-10-30-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 55 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482943/710-10-55-8 + Details
Name: | us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration